标题
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
作者
关键词
-
出版物
Cancers
Volume 14, Issue 4, Pages 1028
出版商
MDPI AG
发表日期
2022-02-18
DOI
10.3390/cancers14041028
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- KEYNOTE-177: Phase III randomized study of pembrolizumab versus chemotherapy for microsatellite instability-high advanced colorectal cancer.
- (2021) Kai-Keen Shiu et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.
- (2021) Andrea Grace Bocobo et al. JOURNAL OF CLINICAL ONCOLOGY
- NK cell-based cancer immunotherapy: from basic biology to clinical development
- (2021) Sizhe Liu et al. Journal of Hematology & Oncology
- Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
- (2021) Jungang Liu et al. Journal of Translational Medicine
- Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600E/K mutated malignant melanomas
- (2021) Sebastian Klein et al. Scientific Reports
- Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
- (2021) Chao Liu et al. Journal for ImmunoTherapy of Cancer
- IL-12 Family Cytokines in Cancer and Immunotherapy
- (2021) Bhalchandra Mirlekar et al. Cancers
- A STING-related prognostic score predicts high-risk patients of colorectal cancer and provides insights into immunotherapy
- (2021) Si-Yuan Chen et al. Annals of Translational Medicine
- E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity
- (2021) Dae‐Shik Kim et al. ChemMedChem
- Targeting a neoantigen derived from a common TP53 mutation
- (2021) Emily Han-Chung Hsiue et al. SCIENCE
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
- (2021) Dan Pu et al. Frontiers in Oncology
- Bispecific antibodies targeting mutant RAS neoantigens
- (2021) Jacqueline Douglass et al. Science Immunology
- PTEN loss correlates with T cell exclusion across human cancers
- (2021) Ziying Lin et al. BMC CANCER
- Novel therapies emerging in oncology to target the TGF-β pathway
- (2021) Byung-Gyu Kim et al. Journal of Hematology & Oncology
- Key biomarkers within the colorectal cancer related inflammatory microenvironment
- (2021) Valentin Calu et al. Scientific Reports
- Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy
- (2021) E Zhou et al. EBioMedicine
- CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
- (2021) Navid Sobhani et al. Cancers
- The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
- (2021) Maurice Michel et al. Cancers
- Phosphatidylserine binding directly regulates TIM-3 function
- (2021) Courtney M. Smith et al. BIOCHEMICAL JOURNAL
- FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
- (2021) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation
- (2021) Timothy D. Martin et al. SCIENCE
- The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
- (2021) Hasan Baysal et al. Frontiers in Immunology
- The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors
- (2021) Min Wang et al. Frontiers in Immunology
- Colorectal Cancer Cell-Derived Small Extracellular Vesicles Educate Human Fibroblasts to Stimulate Migratory Capacity
- (2021) Stefano Piatto Clerici et al. Frontiers in Cell and Developmental Biology
- Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases
- (2021) Chongkai Wang et al. JAMA Network Open
- Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
- (2021) Yu-Chan Chang et al. Biomedicines
- Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
- (2021) Gongmin Zhu et al. Molecular Cancer
- Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells
- (2021) Tanmoy Saha et al. Nature Nanotechnology
- A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs
- (2021) Kelsey E. Huntington et al. Oncotarget
- Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells
- (2021) Lindsey Carlsen et al. Oncotarget
- Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
- (2021) Huabin Hu et al. Lancet Gastroenterology & Hepatology
- Prognostic value of peripheral blood natural killer cells in colorectal cancer
- (2020) Yan-ping Tang et al. BMC GASTROENTEROLOGY
- A Novel GUCY2C-CD3 T cell Engaging Bispecific construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
- (2020) Divya Mathur et al. CLINICAL CANCER RESEARCH
- A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.
- (2020) M. Cecilia Monge B. et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging role of PTEN loss in evasion of the immune response to tumours
- (2020) Thiago Vidotto et al. BRITISH JOURNAL OF CANCER
- Trastuzumab Deruxtecan: First Approval
- (2020) Susan J. Keam DRUGS
- Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
- (2020) Shota Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase Ia/Ib, open-label first-in-human study of the safety, tolerability, and feasibility of gene-edited autologous NeoTCR-T cells (NeoTCR-P1) administered to patients with locally advanced or metastatic solid tumors.
- (2020) Bartosz Chmielowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
- (2020) Chongkai Wang et al. ONCOLOGIST
- A Role for MAIT Cells in Colorectal Cancer
- (2020) Stuart P. Berzins et al. Frontiers in Immunology
- Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
- (2020) Alberto Puccini et al. Journal for ImmunoTherapy of Cancer
- Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer
- (2020) Kethe Hermunen et al. ACTA ONCOLOGICA
- cGAS-STING, an important pathway in cancer immunotherapy
- (2020) Minlin Jiang et al. Journal of Hematology & Oncology
- Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens
- (2020) Azita Moradi et al. PHARMACOLOGICAL RESEARCH
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study
- (2020) Shousheng Liu et al. Scientific Reports
- Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
- (2020) Anqi Lin et al. Frontiers in Immunology
- Interleukin-1β and Cancer
- (2020) Cédric Rébé et al. Cancers
- Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
- (2020) Daria S. Chulpanova et al. Frontiers in Cell and Developmental Biology
- Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study
- (2020) Y. Touchefeu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting EphA2 in cancer
- (2020) Ta Xiao et al. Journal of Hematology & Oncology
- Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy
- (2020) Si-Yu Zhang et al. PHARMACOLOGICAL RESEARCH
- The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
- (2020) Zhi Peng et al. Cancer Immunology Research
- Colorectal Cancer Immunotherapy: Options and Strategies
- (2020) Nor Adzimah Johdi et al. Frontiers in Immunology
- The Confounders of Cancer Immunotherapy: Roles of Lifestyle, Metabolic Disorders and Sociological Factors
- (2020) Ravindra Pramod Deshpande et al. Cancers
- Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
- (2020) Irina Larionova et al. Frontiers in Oncology
- The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy
- (2020) Yun-Qiang Tang et al. Gastroenterology Report
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
- (2020) Thierry André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer
- (2020) Asimina Koulouridi et al. Cancers
- Prognostic value of PD-L1 expression in patients with pancreatic cancer
- (2019) Ying Hu et al. MEDICINE
- A comprehensive study of immunology repertoires in both preoperative stage and postoperative stage in patients with colorectal cancer
- (2019) Xicheng Liu et al. Molecular Genetics & Genomic Medicine
- Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition
- (2019) Girish S. Naik et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- FDA Approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors
- (2019) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts).
- (2019) Maliha Nusrat et al. JOURNAL OF CLINICAL ONCOLOGY
- Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
- (2019) Pengfei Zhao et al. Journal of Hematology & Oncology
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- IL-1 Family Members in Cancer; Two Sides to Every Story
- (2019) Kevin J. Baker et al. Frontiers in Immunology
- U3-1402, a novel HER3-targeting antibody-drug conjugate, for the treatment of Colorectal Cancer
- (2019) Shigehiro Koganemaru et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model
- (2019) Thomas Mueller et al. MOLECULES
- Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches
- (2019) Joseph Tintelnot et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer
- (2019) Marta L. Pinto et al. Frontiers in Immunology
- Application of Newcastle disease virus in the treatment of colorectal cancer
- (2019) Hui Song et al. World Journal of Clinical Cases
- The RNA-binding protein SART3 promotes miR-34a biogenesis and G1 cell cycle arrest in lung cancer cells
- (2019) Emily J. Sherman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- STING: a master regulator in the cancer-immunity cycle
- (2019) Yuanyuan Zhu et al. Molecular Cancer
- Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
- (2019) Xianguang Bai et al. OncoTargets and Therapy
- Engineered T Cell Therapy for Cancer in the Clinic
- (2019) Lijun Zhao et al. Frontiers in Immunology
- The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
- (2019) Mifanwy Reece et al. Frontiers in Genetics
- A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
- (2018) Amita Patnaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell-potentiated colorectal carcinogenesis
- (2018) Guifang Yan et al. CANCER RESEARCH
- MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
- (2018) Henning Reis et al. Clinical Lung Cancer
- Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer
- (2018) Yunxuan Wang et al. Journal of Breast Cancer
- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
- (2018) Jennifer L McQuade et al. LANCET ONCOLOGY
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- (2018) Catherine S. Grasso et al. Cancer Discovery
- Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
- (2018) Shu-Yung Lin et al. Journal of Cancer
- Diagnostic value of peripheral blood immune profiling in colorectal cancer
- (2018) Joungbum Choi et al. Annals of Surgical Treatment and Research
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
- (2018) Tsuyoshi Hamada et al. OncoImmunology
- Mechanisms of Resistance to Immune Checkpoint Blockade
- (2018) David Liu et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells
- (2018) Masayuki Shiozawa et al. BMC IMMUNOLOGY
- Development of a tetravalent anti-GPA33/anti-CD3 bispecific antibody for colorectal cancers
- (2018) Zhihao Wu et al. MOLECULAR CANCER THERAPEUTICS
- Current status of immunotherapy in metastatic colorectal cancer
- (2018) Pawel Wrobel et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The Interferon-Gamma Paradox in Cancer
- (2018) M. Raza Zaidi JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
- (2018) Ziming Wang et al. NATURE MEDICINE
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
- (2017) Valentine Heidelberger et al. INVESTIGATIONAL NEW DRUGS
- Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
- (2017) Lu Zhang et al. JNCI-Journal of the National Cancer Institute
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- The c-Met receptor: Implication for targeted therapies in colorectal cancer
- (2017) Elmira Safaie Qamsari et al. TUMOR BIOLOGY
- ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
- (2017) Arjan Kol et al. Oncotarget
- Panitumumab-Conjugated Pt-Drug Nanomedicine for Enhanced Efficacy of Combination Targeted Chemotherapy against Colorectal Cancer
- (2017) Ming-Hsien Tsai et al. Advanced Healthcare Materials
- Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
- (2017) Lu Zhang et al. JNCI-Journal of the National Cancer Institute
- The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
- (2017) Brad Griesenauer et al. Frontiers in Immunology
- A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
- (2017) Renée C. G. de Bruin et al. OncoImmunology
- Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
- (2016) Sin-Tzu Ning et al. ACS Applied Materials & Interfaces
- Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
- (2016) Jung Ho Kim et al. BRITISH JOURNAL OF CANCER
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
- (2016) M. Bacac et al. CLINICAL CANCER RESEARCH
- The safety of monoclonal antibodies for treatment of colorectal cancer
- (2016) Martin D. Berger et al. Expert Opinion On Drug Safety
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
- (2016) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Molecular pathological classification of colorectal cancer
- (2016) Mike F. Müller et al. VIRCHOWS ARCHIV
- Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer
- (2016) KENJI TAMURA et al. Oncology Letters
- CCR5 antagonist, an ally to fight against metastatic colorectal cancer
- (2016) Naofumi Mukaida Translational Cancer Research
- HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver
- (2015) Frida Lédel et al. ACTA ONCOLOGICA
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
- (2015) Se Hoon Park et al. MOLECULAR THERAPY
- MUC1-C activates the TAK1 inflammatory pathway in colon cancer
- (2015) H Takahashi et al. ONCOGENE
- Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes
- (2015) Andrew D. Skora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy
- (2015) D. J. George et al. Cancer Immunology Research
- High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
- (2015) Yueh-Min Lin et al. PLoS One
- Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy
- (2014) D E Oppenheim et al. BRITISH JOURNAL OF CANCER
- Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases
- (2014) A Saied et al. CANCER GENE THERAPY
- Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
- (2014) Timothy J Price et al. LANCET ONCOLOGY
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- How Thalidomide Works Against Cancer
- (2014) A. K. Stewart SCIENCE
- Antigen-specific vaccines for cancer treatment
- (2014) Maria Tagliamonte et al. Human Vaccines & Immunotherapeutics
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
- (2013) Raoul A. Droeser et al. EUROPEAN JOURNAL OF CANCER
- Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
- (2011) Martha L. Slattery et al. CARCINOGENESIS
- Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer
- (2011) V. A. de Weger et al. CLINICAL CANCER RESEARCH
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Inverse Relationship Between Moderate Alcohol Intake and Rectal Cancer: Analysis of the North Carolina Colon Cancer Study
- (2011) Seth D. Crockett et al. DISEASES OF THE COLON & RECTUM
- The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21
- (2011) Dimitrios Iliopoulos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
- (2010) M. Fakih et al. Current Oncology
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
- (2010) Sunil K. Geevarghese et al. HUMAN GENE THERAPY
- Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
- (2010) Pierpaolo Correale et al. JOURNAL OF IMMUNOTHERAPY
- Up-regulation of NKG2F receptor, a functionally unknown killer receptor, of human natural killer cells by interleukin-2 and interleukin-15
- (2010) Sun ONCOLOGY REPORTS
- Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- KLF4-dependent, PPARγ-induced expression of GPA33 in colon cancer cell lines
- (2009) Julie Rageul et al. INTERNATIONAL JOURNAL OF CANCER
- Development of monoclonal antibodies for the treatment of colorectal cancer
- (2008) S. Goodin AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
- (2008) A Walther et al. GUT
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started